Clinical Trial Update: Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma

View source ↗

Summary

Clinical trial update indicates validation of blood-based biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization (TACE). T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Neoplasms

Snippet

Sponsor: University of Belgrade | Conditions: Hepatocellular Carcinoma (HCC), Liver Neoplasms | Status: NOT_YET_RECRUITING